Wellington Management Group LLP Xeris Biopharma Holdings, Inc. Transaction History
Wellington Management Group LLP
- $529 Billion
- Q2 2025
A detailed history of Wellington Management Group LLP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 399,291 shares of XERS stock, worth $3.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
399,291
Previous 392,099
1.83%
Holding current value
$3.21 Million
Previous $2.15 Million
13.38%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding XERS
# of Institutions
207Shares Held
89.4MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$78.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$30.8 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$30.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$29.3 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.09B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...